List of life saving transplantations

The ultimate goal of our service is to use stored stem cells for transplantations. For this reason we are proud to have been by our customers’ side time and time again during difficult circumstances by collecting, storing and preparing life-saving biological material for transplantation.

Filter by

No. Cell source Indication Area of medicine Year Type of therapy Country Recipient age
1 cord blood talassemia major hematology 2018 standard therapy Turkey 9,5
2 autologous cord blood aplastic anaemia hematology 2018 standard therapy Poland 3,5
3 cord blood chronic granulomatous disease hematology 2017 standard therapy Turkey 3,9
4 autologous cord blood autism neurology 2017 experimental therapy Poland 4,1
5 autologous cord blood autism neurology 2017 experimental therapy Poland 4,1
6 autologous cord blood autism neurology 2017 experimental therapy Poland 5,4
7 autologous cord blood autism neurology 2017 experimental therapy Poland 7,3
8 autologous cord blood autism neurology 2017 experimental therapy Poland 6,2
9 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 6,8
10 cord blood relapse of acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7,3
11 autologous cord blood autism neurology 2017 experimental therapy Poland 4,11
12 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 10,3
13 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 5,4
14 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 2,2
15 cord blood talassemia major hematology 2017 standard therapy Turkey 4,1
16 cord blood talassemia major hematology 2017 standard therapy Turkey 4,0
17 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9,6
18 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
19 autologous cord blood autism neurology 2016 experimental therapy Poland 6
20 cord blood + peripheral blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
21 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
22 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
23 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
24 cord blood beta-talassemia, agranulocytosis hematology 2013 standard therapy Turkey 8
25 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
26 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
27 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
28 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3,5
29 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
30 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
31 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7,5
32 cord blood histiocytosis hematology 2011 standard therapy Poland 2,5
33 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
34 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
35 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
36 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1,5
37 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
38 autologous cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1,5
39 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
40 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
41 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 68,5
42 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 31,11
43 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 25,5
44 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 36,3
45 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 61,11
46 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 16,7
47 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2018 experimental therapy Poland 44,11
48 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 3,7
49 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 59,10
50 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 48,11
51 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 44,3
52 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 52,8
53 cord tissue (Wharton's jelly) spina bifida neurology 2018 experimental therapy Poland 2,6
54 cord tissue (Wharton's jelly) myopathy neurology 2018 experimental therapy Poland 57,3
55 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 28,1
56 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 66,8
57 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 67,10
58 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2018 experimental therapy Poland 1,11
59 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2018 experimental therapy Poland 34,7
60 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 41,8
61 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 32,3
62 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 46,7
63 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 39,5
64 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 55,4
65 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 36,6
66 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 34,11
67 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 27,2
68 cord tissue (Wharton's jelly) spina bifida neurology 2018 experimental therapy Poland 3,1
69 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2018 experimental therapy Poland 33,11
70 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 52,3
71 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 66,3
72 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 47,8
73 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 59,3
74 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 50,8
75 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 51,9
76 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 38,6
77 cord tissue (Wharton's jelly) developmental delay neurology 2018 experimental therapy Poland 14
78 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 46,2
79 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 38,1
80 cord tissue (Wharton's jelly) spinal cord injury neurology 2018 experimental therapy Poland 30,9
81 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,2
82 cord tissue (Wharton's jelly) epilepsia neurology 2018 experimental therapy Poland 20,9
83 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2018 experimental therapy Poland 46,7
84 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 30,4
85 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 44,2
86 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 34,2
87 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2018 experimental therapy Poland 20,6
88 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 55,8
89 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 9,2
90 cord tissue (Wharton's jelly) stroke neurology 2018 experimental therapy Poland 70,1
91 cord tissue (Wharton's jelly) Friedreich's ataxia neurology 2018 experimental therapy Poland 27,6
92 cord tissue (Wharton's jelly) Friedreich's ataxia neurology 2018 experimental therapy Poland 31,5
93 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2018 experimental therapy Poland 46,1
94 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 47,3
95 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 52,11
96 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 28,6
97 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 3,8
98 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 8,5
99 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 62,5
100 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 21,7
101 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 40,0
102 cord tissue (Wharton's jelly) developmental delay neurology 2018 experimental therapy Poland 7,11
103 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 9,0
104 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 2,11
105 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 8,3
106 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 6,10
107 cord tissue (Wharton's jelly) encephalopathy neurology 2018 experimental therapy Poland 54,8
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 54,2
109 cord tissue (Wharton's jelly) damage to the intercondylar fissure of the right knee orthopedics 2018 experimental therapy Poland 40,2
110 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2018 experimental therapy Poland 7,0
111 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 67,11
112 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 41,9
113 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 35
114 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 83,5
115 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 57,8
116 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 57,5
117 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 45,11
118 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 28,6
119 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 61,3
120 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 20,8
121 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2018 experimental therapy Poland 34,1
122 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 75,5
123 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 4,11
124 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2018 experimental therapy Poland 27,4
125 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 80,3
126 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 2,4
127 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 9,4
128 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 76,1
129 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 54,4
130 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 35,1
131 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 80,5
132 cord tissue (Wharton's jelly) spinal cord injury neurology 2018 experimental therapy Poland 25,9
133 cord tissue (Wharton's jelly) holoprosencephalia neurology 2018 experimental therapy Poland 12,2
134 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2018 experimental therapy Poland 8,8
135 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 22,6
136 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,7
137 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,2
138 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 60,2
139 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 31,2
140 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 40,9
141 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 70,11
142 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 9,5
143 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2018 experimental therapy Poland 1,9
144 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 10,9
145 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 64,4
146 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 47,1
147 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 66,2
148 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2018 experimental therapy Poland b/d
149 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 75,7
150 cord tissue (Wharton's jelly) spina bifida neurology 2018 experimental therapy Poland 4,11
151 cord tissue (Wharton's jelly) encephalopathy, cerebral palsy neurology 2018 experimental therapy Poland 22,1
152 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 13,1
153 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 2,4
154 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2018 experimental therapy Poland 6,2
155 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 67,9
156 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 62
157 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 38,2
158 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 44,0
159 cord tissue (Wharton's jelly) stroke neurology 2018 experimental therapy Poland 53,4
160 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 3,10
161 cord tissue (Wharton's jelly) Other reduction deformities of brain, Schizencephaly neurology 2018 experimental therapy Poland 5,7
162 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 49,2
163 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 4,5
164 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita, epilepsia neurology 2018 experimental therapy Poland 6,3
165 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 64,5
166 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 63,7
167 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 5,11
168 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 39,1
169 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 47,3
170 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 67,1
171 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 64,7
172 cord tissue (Wharton's jelly) spinal cord injury neurology 2018 experimental therapy Poland 25,9
173 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 6,3
174 cord tissue (Wharton's jelly) epilepsia neurology 2018 experimental therapy Poland 13,3
175 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 7,1
176 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 11,11
177 cord tissue (Wharton's jelly) delayed psychomotor development, atrophy of the optic nerves neurology 2018 experimental therapy Poland 2,0
178 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2018 experimental therapy Poland 16,1
179 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 5,11
180 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2018 experimental therapy Poland 28,11
181 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 62,1
182 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
183 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
184 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
185 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
186 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
187 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
188 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
189 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
190 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
191 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,0
192 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
193 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 37,7
194 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
195 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
196 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
197 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
198 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
199 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
200 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
201 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
202 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
203 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
204 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
205 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
206 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
207 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30,0
208 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
209 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
210 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
211 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
212 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
213 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
214 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
215 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
216 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
217 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
218 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,0
219 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
220 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39,0
221 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
222 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
223 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
224 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
225 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
226 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
227 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,7
228 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
229 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 22,1
230 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
231 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3,1
232 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5,2
233 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8,3
234 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42,6
235 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,9
236 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,2
237 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38,5
238 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
239 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,4
240 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21,10
241 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,0
242 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41,0
243 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,1
244 cord tissue (Wharton's jelly) cerebral palsy, neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1,9
245 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11,11
246 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26,10
247 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9,1
248 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11,5
249 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1,10
250 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5,11
251 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,5
252 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40,11
253 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,1
254 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,11
255 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 37,11
256 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1,7
257 cord tissue (Wharton's jelly) encephalopathy, cerebral palsy neurology 2017 experimental therapy Poland 4,4
258 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 5,8
259 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6,4
260 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,4
261 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9,4
262 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14,1
263 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17,11
264 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69,10
265 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24,9
266 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,7
267 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,1
268 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,11
269 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27,11
270 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45,4
271 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34,10
272 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 31,6
273 cord tissue (Wharton's jelly) hydrocephalus, neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2,3
274 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,3
275 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
276 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3,5
277 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6,3
278 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3,5
279 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52,0
280 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13,0
281 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11,10
282 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,11
283 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37,11
284 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,1
285 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
286 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77,2
287 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,11
288 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63,11
289 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,6
290 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,9
291 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31,9
292 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,2
293 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33,5
294 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,7
295 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12,5
296 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
297 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
298 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5,0
299 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,9
300 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6,3
301 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
302 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
303 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45,5
304 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31,5
305 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48,10
306 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 62,5
307 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,5
308 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,1
309 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
310 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,4
311 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,3
312 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,0
313 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,1
314 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19,7
315 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 35,4
316 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,10
317 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,8
318 cord tissue (Wharton's jelly) encephalopathy, cerebral palsy neurology 2017 experimental therapy Poland 1,5
319 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,0
320 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
321 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6,7
322 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32,3
323 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46,9
324 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,10
325 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41,11
326 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4,7
327 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56,4
328 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4,1
329 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,6
330 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33,4
331 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 42,1
332 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 2,4
333 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 30,11
334 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,7
335 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
336 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,2
337 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,4
338 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,11
339 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 7,9
340 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3,5
341 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 3,2
342 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,2
343 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 76,10
344 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23,9
345 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
346 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43,8
347 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 74,5
348 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,7
349 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
350 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70,11
351 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65,1
352 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,5
353 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,4
354 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,1
355 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,8
356 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
357 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 12,10
358 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26,9
359 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,4
360 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,8
361 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,1
362 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,9
363 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,5
364 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
365 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,5
366 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,1
367 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,4
368 cord tissue (Wharton's jelly) Devic’s disease neurology 2017 experimental therapy Poland 45,2
369 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 31,3
370 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,10
371 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,3
372 cord tissue (Wharton's jelly) epilepsia, autism neurology 2017 experimental therapy Poland 6,0
373 cord tissue (Wharton's jelly) myopathy of congenital fiber type disproportion, damage to the central nervous system neurology 2017 experimental therapy Poland 2,2
374 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,7
375 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 68,1
376 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,3
377 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 49,1
378 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
379 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 7,11
380 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,8
381 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,11
382 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 10,8
383 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
384 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 38,0
385 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 25,2
386 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 58,7
387 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,2
388 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,7
389 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
390 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,0
391 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 62,9
392 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 57,9
393 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,11
394 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,5
395 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 53,9
396 cord tissue (Wharton's jelly) leukodystrophy neurology 2017 experimental therapy Poland 7,1
397 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 35,5
398 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 16,4
399 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
400 cord tissue (Wharton's jelly) tetraparesis orthopedics 2017 experimental therapy Poland 27,11
401 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 8,10
402 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 9,11
403 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
404 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,3
405 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 3,6
406 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
407 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,4
408 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 55,2
409 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 53,10
410 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
411 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
412 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,3
413 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
414 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 27,3
415 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,0
416 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,9
417 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,6
418 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,4
419 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,3
420 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,6
421 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 77,5
422 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,6
423 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,6
424 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 33,8
425 cord tissue (Wharton's jelly) condition after myelitis neurology 2017 experimental therapy Poland 34,11
426 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,11
427 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 22,4
428 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 9,10
429 cord tissue (Wharton's jelly) delayed psychomotor development, epilepsia neurology 2017 experimental therapy Poland 11,8
430 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 18,5
431 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,8
432 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
433 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,0
434 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 1,6
435 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 32,9
436 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,6
437 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,11
438 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 22,10
439 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 44,0
440 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,7
441 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,8
442 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 3,4
443 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 12,11
444 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,3
445 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 65,6
446 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,10
447 cord tissue (Wharton's jelly) tetraparesis spastica, epilepsia neurology 2017 experimental therapy Poland 2,8
448 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,10
449 cord tissue (Wharton's jelly) spinal cord injury, tetraparesis orthopedics 2017 experimental therapy Poland 42,9
450 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
451 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 11,10
452 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 24,8
453 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 38,4
454 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 14,5
455 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,1
456 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 12,2
457 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 66,8
458 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 85,7
459 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,1
460 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
461 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 28,7
462 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
463 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 8,0
464 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 52,6
465 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 35,9
466 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,11
467 cord tissue (Wharton's jelly) congenital malformations of the nervous system, unspecified neurology 2017 experimental therapy Poland 8,2
468 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 10,3
469 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
470 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
471 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 29,8
472 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,5
473 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,7
474 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,10
475 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,9
476 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 17,0
477 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,6
478 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 52,8
479 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 2,1
480 cord tissue (Wharton's jelly) autism, encephalopathy neurology 2017 experimental therapy Poland 7,11
481 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
482 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 5,10
483 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 69,2
484 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 64,3
485 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 46,10
486 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,1
487 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,10
488 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 59,0
489 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 46,5
490 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
491 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,5
492 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,2
493 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,4
494 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,6
495 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 7,4
496 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2017 experimental therapy Poland 33,0
497 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,9
498 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,3
499 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
500 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,8
501 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
502 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 7,6
503 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,10
504 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,8
505 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 8,3
506 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 15,9
507 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 14,4
508 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,2
509 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,5
510 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
511 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 7,11
512 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 9/12
513 cord tissue (Wharton's jelly) moyamoya disease neurology 2017 experimental therapy Poland 17,7
514 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2017 experimental therapy Poland 67,7
515 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 57,1
516 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,8
517 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
518 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
519 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
520 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
521 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
522 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
523 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
524 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
525 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
526 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
527 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
528 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
529 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
530 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
531 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
532 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
533 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
534 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
535 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
536 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
537 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
538 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
539 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
540 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
541 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
542 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
543 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
544 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
545 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
546 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
547 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
548 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
549 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
550 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
551 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
552 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
553 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
554 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
555 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
556 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
557 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
558 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
559 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
560 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
561 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
562 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
563 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
564 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
565 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
566 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
567 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
568 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
569 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
570 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
571 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
572 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
573 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
574 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
575 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
576 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
577 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
578 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
579 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
580 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
581 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
582 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
583 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
584 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
585 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
586 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
587 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
588 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
589 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
590 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
591 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
592 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
593 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
594 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
595 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
596 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45,1
597 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
598 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36,1
599 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
600 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
601 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,7
602 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,1
603 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,1
604 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,4
605 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,3
606 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,1
607 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,8
608 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,7
609 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
610 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
611 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
612 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
613 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
614 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
615 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
616 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
617 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,10
618 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
619 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
620 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
621 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
622 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
623 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
624 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
625 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
626 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
627 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
628 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
629 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
630 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
631 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
632 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
633 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
634 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
635 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
636 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
637 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
638 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
639 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
640 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
641 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
642 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
643 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
644 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
645 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
646 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
647 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
648 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
649 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
650 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
651 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
652 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
653 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
654 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
655 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,8
656 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,5
657 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
658 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,9
659 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6,9
660 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,8
661 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,6
662 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13,2
663 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7,4
664 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7,4
665 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
666 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,1
667 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,4
668 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
669 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
670 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
671 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
672 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
673 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
674 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
675 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23,6
676 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86,5
677 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54,6
678 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
679 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
680 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
681 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
682 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
683 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
684 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
685 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
686 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
687 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
688 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
689 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 30,3
690 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
691 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
692 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
693 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
694 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
695 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
696 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
697 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
698 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
699 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
700 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
701 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
702 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
703 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
704 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
705 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
706 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
707 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
708 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 32,3
709 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
710 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
711 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
712 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
713 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
714 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
715 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
716 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
717 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
718 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
719 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
720 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
721 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
722 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
723 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
724 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
725 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
726 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
727 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
728 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
729 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
730 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
731 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
732 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
733 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
734 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
735 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
736 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
737 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,4
738 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41,2
739 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,1
740 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,8
741 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
742 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
743 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
744 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
745 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
746 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
747 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
748 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
749 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
750 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3,6
751 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70,8
752 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
753 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
754 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
755 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
756 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
757 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
758 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
759 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
760 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
761 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
762 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 44,7
763 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
764 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
765 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
766 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
767 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
768 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
769 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
770 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
771 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
772 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
773 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
774 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
775 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
776 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
777 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
778 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
779 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
780 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35,5
781 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
782 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
783 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
784 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
785 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
786 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
787 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
788 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
789 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
790 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
791 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
792 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
793 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
794 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
795 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
796 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
797 cord tissue (Wharton's jelly) bilateral blindness phthalmology 2015 experimental therapy Poland 36,10
798 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
799 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
800 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
801 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
802 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
803 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
804 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
805 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
806 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
807 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
808 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
809 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
810 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
811 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
812 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
813 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
814 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
815 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
816 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
817 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
818 cord tissue (Wharton's jelly) adrenoleukodystrophy, encephalopathy neurology 2015 experimental therapy Poland 23
819 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
820 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
821 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
822 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
823 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
824 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
825 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
826 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
827 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
828 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
829 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
830 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
831 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
832 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
833 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
834 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
835 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
836 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
837 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
838 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
839 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
840 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
841 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
842 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
843 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
844 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
845 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
846 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
847 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
848 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
849 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
850 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
851 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
852 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
853 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
854 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
855 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
856 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
857 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
858 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
859 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
860 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
861 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
862 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
863 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
864 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
865 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
866 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
867 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
868 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
869 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
870 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
871 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
872 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
873 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
874 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
875 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
876 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
877 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
878 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
879 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
880 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
881 cord tissue (Wharton's jelly) adrenoleukodystrophy, encephalopathy neurology 2015 experimental therapy Poland 8,4
882 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23,6
883 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
884 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
885 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
886 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
887 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
888 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
889 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
890 cord tissue (Wharton's jelly) birth asphyxia, retinopathy neurology 2014 experimental therapy Poland 11/12
891 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
892 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
893 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18,9
894 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2,11
895 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3,5
896 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3,5
897 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18,8
898 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17,5
899 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19,7
900 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7,1
901 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4,3
902 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17,2
903 bone marrow myelodysplastic syndrome hematology 2018 standard therapy Italy 4
904 bone marrow chronic granulomatous disease hematology 2018 standard therapy Switzerland 3
905 bone marrow juvenile myelomonocytic leukemia hematology 2018 standard therapy Hungary 11
906 bone marrow Hodgkin’s lymphoma hematology 2018 standard therapy USA 31
907 bone marrow bilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemia hematology 2018 standard therapy Belarus 2
908 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Italy 3/4
909 bone marrow acute myelogenous leukemia hematology 2018 standard therapy Switzerland 67
910 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Brazil 3
911 bone marrow no data hematology 2018 standard therapy Spain 48
912 bone marrow no data hematology 2018 standard therapy Germany 16
913 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Poland 12
914 bone marrow acute myelogenous leukemia hematology 2018 standard therapy Italy 36
915 bone marrow thalassemia major hematology 2018 standard therapy Sweden 14
916 bone marrow severe aplastic anaemia hematology 2018 standard therapy USA 19
917 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy USA 50
918 bone marrow diffuse large B-cell lymphoma hematology 2018 standard therapy Germany 68
919 bone marrow severe combined immunodeficiency hematology 2018 standard therapy Israel 2
920 bone marrow severe aplastic anaemia hematology 2018 standard therapy Italy 14
921 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy USA 11
922 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Argentina 14
923 bone marrow chronic granulomatous disease hematology 2018 standard therapy USA 2
924 bone marrow severe combined immunodeficiency hematology 2018 standard therapy USA 1
925 bone marrow acute myelogenous leukemia hematology 2018 standard therapy USA 20
926 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Canada 8
927 bone marrow acute myelogenous leukemia hematology 2018 standard therapy USA 1
928 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
929 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
930 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
931 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
932 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
933 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
934 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
935 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
936 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
937 bone marrow leukemia hematology 2017 standard therapy USA 40
938 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
939 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
940 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
941 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
942 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
943 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
944 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
945 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
946 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
947 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
948 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
949 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
950 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
951 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
952 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
953 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
954 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
955 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
956 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
957 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
958 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
959 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
960 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
961 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
962 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10
963 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10
964 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17
965 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51
966 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1
967 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2
968 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51
969 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56
970 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54
971 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24
972 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Poland 1
973 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8
974 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 9
975 bone marrow no data hematology 2017 standard therapy France 32
976 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 14
977 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 4
978 bone marrow Wiskott-Aldrich syndrome hematology 2017 standard therapy Iran 2
979 bone marrow T-cell leukemia/lymphoma hematology 2017 standard therapy Iran 18
980 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 7
981 bone marrow myeloma multiplex hematology 2017 standard therapy Canada 50
982 bone marrow other combined immunodeficiency hematology 2017 standard therapy USA 11
983 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 2
984 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 12
985 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Norway 2
986 bone marrow Nijmegen breakage syndrome hematology 2017 standard therapy Poland 8
987 bone marrow secondary acute myelogenous leukemiaafter Ewing sarcoma hematology 2017 standard therapy Germany 16
988 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy India 7
989 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 18
990 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 2
991 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 8
992 bone marrow Fanconi anaemia hematology 2017 standard therapy Belarus 10
993 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 7
994 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 19
995 bone marrow primary Immunodeficiency, Nijmegen breakage syndrome hematology 2017 standard therapy Belarus 6
996 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
997 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
998 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
999 bone marrow no data n/a 2016 standard therapy Italy 3
1000 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
1001 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
1002 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
1003 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
1004 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
1005 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
1006 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
1007 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
1008 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
1009 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
1010 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
1011 bone marrow no data n/a 2016 standard therapy Poland 7
1012 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
1013 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
1014 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
1015 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
1016 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
1017 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
1018 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
1019 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
1020 bone marrow  evere combined immunodeficiency hematology 2016 standard therapy Poland 7/12
1021 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
1022 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
1023 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
1024 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
1025 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
1026 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
1027 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
1028 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
1029 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
1030 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
1031 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
1032 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1033 bone marrow no data n/a 2016 standard therapy Poland 33
1034 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
1035 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
1036 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
1037 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
1038 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
1039 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
1040 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
1041 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
1042 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
1043 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
1044 bone marrow anaemia hematology 2016 standard therapy Germany 16
1045 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
1046 bone marrow anaemia hematology 2016 standard therapy Italy 5
1047 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
1048 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 26
1049 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 35
1050 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Canada 59
1051 peripheral blood myelofibrosis hematology 2018 standard therapy Netherlands 49
1052 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy United Kingdom 29
1053 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy United Kingdom 42
1054 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 74
1055 peripheral blood severe aplastic anaemia hematology 2018 standard therapy Germany 18
1056 peripheral blood T-cell acute lymphoblastic leukemia hematology 2018 standard therapy Germany 7
1057 peripheral blood myeloma multiplex hematology 2018 standard therapy Lithuania 56
1058 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 63
1059 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy United Kingdom 46
1060 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy Poland 23
1061 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 66
1062 peripheral blood other myleofibrosis hematology 2018 standard therapy Poland 57
1063 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Italy 65
1064 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Poland 48
1065 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy France 46
1066 peripheral blood secondary acute myelogenous leukemia hematology 2018 standard therapy Poland 58
1067 peripheral blood acute myeloid leukemia in first complete remission hematology 2018 standard therapy Germany 61
1068 peripheral blood Hodgkin’s lymphoma hematology 2018 standard therapy Poland 38
1069 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Spain 34
1070 peripheral blood myelofibrosis hematology 2018 standard therapy Germany 60
1071 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 72
1072 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy France 50
1073 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy France 33
1074 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 61
1075 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 45
1076 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 45
1077 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Italy 67
1078 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 30
1079 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 71
1080 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 42
1081 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Netherlands 67
1082 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 56
1083 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 54
1084 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 72
1085 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Poland 59
1086 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 61
1087 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 51
1088 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 64
1089 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 61
1090 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 50
1091 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 47
1092 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 64
1093 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Italy 62
1094 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2018 standard therapy Germany 41
1095 peripheral blood T-cell acute lymphoblastic leukemia hematology 2018 standard therapy Poland 13
1096 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 68
1097 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 62
1098 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 8
1099 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 54
1100 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Poland 67
1101 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy United Kingdom 22
1102 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Slovenia 54
1103 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 64
1104 peripheral blood myeloma multiplex hematology 2018 standard therapy USA 57
1105 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Italy 61
1106 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 46
1107 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 76
1108 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Poland 50
1109 peripheral blood primary myelofibrosis, secondary acute myelogenous leukemia hematology 2018 standard therapy Germany 53
1110 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Poland 64
1111 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 38
1112 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Germany 8
1113 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 58
1114 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Germany 77
1115 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy USA 69
1116 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Canada 23
1117 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2018 standard therapy Switzerland 50
1118 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy USA 70
1119 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 60
1120 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 71
1121 peripheral blood chronic myelomonocytic leukaemia hematology 2018 standard therapy USA 39
1122 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy France 25
1123 peripheral blood myelofibrosis hematology 2018 standard therapy Sweden 56
1124 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Sweden 60
1125 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy Germany 17
1126 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy USA 31
1127 peripheral blood chronic myelomonocytic leukaemia hematology 2018 standard therapy USA 63
1128 peripheral blood Fanconi anaemia hematology 2018 standard therapy USA 9
1129 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Poland 49
1130 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 28
1131 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Belgium 68
1132 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 66
1133 peripheral blood leukemia hematology 2018 standard therapy Germany 34
1134 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy UK 37
1135 peripheral blood myelodysplastic syndrome, acute myelogenous leukemia hematology 2018 standard therapy USA 74
1136 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
1137 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
1138 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
1139 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
1140 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
1141 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
1142 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
1143 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
1144 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
1145 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
1146 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
1147 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
1148 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
1149 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
1150 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
1151 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
1152 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
1153 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
1154 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
1155 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1156 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
1157 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
1158 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
1159 peripheral blood no data n/a 2017 standard therapy France 39
1160 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
1161 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
1162 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
1163 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
1164 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
1165 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
1166 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
1167 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
1168 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
1169 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1170 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
1171 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
1172 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
1173 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
1174 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
1175 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
1176 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
1177 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
1178 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
1179 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
1180 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
1181 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
1182 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
1183 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1184 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
1185 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
1186 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
1187 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
1188 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
1189 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
1190 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
1191 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
1192 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
1193 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
1194 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
1195 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
1196 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
1197 peripheral blood no data hematology 2017 standard therapy Poland 39
1198 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
1199 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1200 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
1201 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
1202 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
1203 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
1204 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
1205 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
1206 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42
1207 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1208 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
1209 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
1210 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
1211 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
1212 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
1213 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
1214 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1215 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
1216 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
1217 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
1218 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
1219 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
1220 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
1221 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
1222 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
1223 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
1224 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1225 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
1226 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
1227 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
1228 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
1229 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
1230 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1231 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1232 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
1233 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
1234 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
1235 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
1236 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
1237 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
1238 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
1239 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
1240 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
1241 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
1242 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
1243 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
1244 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
1245 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
1246 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
1247 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
1248 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
1249 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
1250 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1251 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
1252 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
1253 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
1254 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
1255 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
1256 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
1257 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
1258 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
1259 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
1260 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1261 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12
1262 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29
1263 peripheral blood no data hematology 2017 standard therapy Germany 65
1264 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4
1265 peripheral blood no data hematology 2017 standard therapy Russia 36
1266 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58
1267 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54
1268 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1269 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1270 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49
1271 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38
1272 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38
1273 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32
1274 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36
1275 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
1276 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1277 peripheral blood no data hematology 2017 standard therapy Kanada 32
1278 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63
1279 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63
1280 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4
1281 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39
1282 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62
1283 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65
1284 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58
1285 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67
1286 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58
1287 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1288 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1289 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19
1290 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67
1291 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43
1292 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68
1293 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69
1294 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11
1295 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4
1296 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42
1297 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1298 peripheral blood no data hematology 2017 standard therapy Poland 58
1299 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 25
1300 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 55
1301 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1302 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 76
1303 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1304 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 41
1305 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 49
1306 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1307 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 2
1308 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1309 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1310 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1311 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 35
1312 peripheral blood no data hematology 2017 standard therapy Poland 53
1313 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 70
1314 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
1315 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 52
1316 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 74
1317 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 30
1318 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
1319 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 31
1320 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 64
1321 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1322 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 49
1323 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 27
1324 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1325 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 22
1326 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 32
1327 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 44
1328 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 53
1329 peripheral blood other malignancy hematology 2017 standard therapy France 59
1330 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Italy 57
1331 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 54
1332 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 61
1333 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 40
1334 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 53
1335 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 58
1336 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy United Kingdom 51
1337 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1338 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 56
1339 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1340 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 46
1341 peripheral blood primary myelofibrosis hematology 2017 standard therapy Germany 29
1342 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1343 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 59
1344 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 63
1345 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Italy 61
1346 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Poland 63
1347 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1348 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 16
1349 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 17
1350 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Greece 28
1351 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Spain 28
1352 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 36
1353 peripheral blood myelofibrosis hematology 2017 standard therapy Netherlands 72
1354 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 69
1355 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 51
1356 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 56
1357 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 43
1358 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1359 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
1360 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Germany 7
1361 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 21
1362 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
1363 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 71
1364 peripheral blood primary myelofibrosis hematology 2017 standard therapy Poland 32
1365 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 24
1366 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1367 peripheral blood myelofibrosis hematology 2017 standard therapy USA 47
1368 peripheral blood blastic plasmacytoid denditic cell neoplasm hematology 2017 standard therapy Germany 56
1369 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 52
1370 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 66
1371 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
1372 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 69
1373 peripheral blood no data hematology 2017 standard therapy Poland 1
1374 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 66
1375 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 67
1376 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
1377 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 65
1378 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
1379 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1380 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
1381 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 59
1382 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 63
1383 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Israel 37
1384 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 23
1385 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 6
1386 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Russia 16
1387 peripheral blood secondary acute myelogenous leukemia hematology 2017 standard therapy Austria 24
1388 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 26
1389 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 46
1390 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 68
1391 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 55
1392 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
1393 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1394 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 72
1395 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 58
1396 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 61
1397 peripheral blood no data hematology 2017 standard therapy Canada 55
1398 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 64
1399 peripheral blood myeloma multiplex hematology 2017 standard therapy USA 57
1400 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 61
1401 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 22
1402 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 40
1403 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1404 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 27
1405 peripheral blood myeloma multiplex hematology 2017 standard therapy Poland 38
1406 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 57
1407 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1408 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1409 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1410 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 24
1411 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1412 peripheral blood Hodgkin’s lymphoma hematology 2017 standard therapy USA 25
1413 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 57
1414 peripheral blood myelodysplastic syndrome in Fanconi anaemia hematology 2017 standard therapy Italy 23
1415 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 60
1416 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 70
1417 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 10
1418 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 26
1419 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 37
1420 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 8
1421 peripheral blood no data hematology 2017 standard therapy Switzerland 68
1422 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
1423 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 13
1424 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
1425 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
1426 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
1427 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1428 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
1429 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
1430 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
1431 peripheral blood no data n/a 2016 standard therapy Netherlands 70
1432 peripheral blood no data n/a 2016 standard therapy Poland 43
1433 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1434 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
1435 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
1436 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1437 peripheral blood no data n/a 2016 standard therapy Netherlands 69
1438 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
1439 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
1440 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
1441 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
1442 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
1443 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1444 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
1445 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1446 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
1447 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
1448 peripheral blood no data n/a 2016 standard therapy Poland 28
1449 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
1450 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
1451 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
1452 peripheral blood no data n/a 2016 standard therapy Belgium 30
1453 peripheral blood no data n/a 2016 standard therapy Germany 71
1454 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
1455 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
1456 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
1457 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1458 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
1459 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
1460 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
1461 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
1462 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
1463 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
1464 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
1465 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
1466 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
1467 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
1468 peripheral blood no data n/a 2016 standard therapy Sweden 58
1469 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1470 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
1471 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1472 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
1473 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
1474 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
1475 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
1476 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
1477 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
1478 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
1479 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
1480 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
1481 peripheral blood no data n/a 2016 standard therapy Germany 17
1482 peripheral blood no data n/a 2016 standard therapy France 59
1483 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1484 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
1485 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
1486 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
1487 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
1488 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
1489 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
1490 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
1491 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
1492 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
1493 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
1494 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
1495 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
1496 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
1497 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
1498 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
1499 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
1500 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
1501 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1502 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
1503 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
1504 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
1505 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
1506 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
1507 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
1508 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
1509 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
1510 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
1511 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
1512 peripheral blood no data n/a 2016 standard therapy Netherlands 58
1513 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
1514 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
1515 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
1516 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1517 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
1518 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
1519 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
1520 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
1521 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
1522 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1523 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
1524 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1525 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
1526 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
1527 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
1528 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
1529 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
1530 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
1531 peripheral blood no data n/a 2016 standard therapy Poland 55
1532 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1533 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
1534 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
1535 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
1536 peripheral blood myelodysplastic syndrome- RCMD hematology 2016 standard therapy Czech Republic 32
1537 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
1538 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
1539 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 2/3
1540 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
1541 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1542 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
1543 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
1544 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
1545 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
1546 peripheral blood no data n/a 2016 standard therapy Turkey 4
1547 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
1548 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
1549 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
1550 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
1551 peripheral blood no data n/a 2016 standard therapy Poland 44
1552 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
1553 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
1554 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
1555 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
1556 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
1557 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
1558 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
1559 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
1560 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
1561 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
1562 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
1563 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
1564 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
1565 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
1566 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
1567 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
1568 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
1569 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
1570 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1571 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1572 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
1573 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
1574 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
1575 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
1576 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
1577 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
1578 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
1579 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
1580 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
1581 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
1582 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
1583 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1584 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
1585 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
1586 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
1587 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1588 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
1589 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
1590 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
1591 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
1592 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
1593 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
1594 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
1595 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
1596 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1597 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
1598 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
1599 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
1600 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
1601 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
1602 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1603 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
1604 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
1605 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
1606 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
1607 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
1608 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
1609 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
1610 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
1611 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1612 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
1613 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
1614 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
1615 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
1616 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
1617 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
1618 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: 31.05.2018